News
MSU professor honing genetic scalpel with backing of biotech company
March 22, 2018 /
A Montana State University professor of microbiology and immunology has received funding to fine-tune a revolutionary method to treat genetic disorders.
Blake Wiedenheft, assistant professor in MSU’s Department of Microbiology and Immunology in the College of Agriculture and the College of Letters & Science, will receive $440,000 from California-based biopharmaceutical company Amgen. The funding will flow through SurGene, a biotech company Wiedenheft founded in December 2016 after Amgen expressed an interest in funding his research through a startup company.
Troy Carter, TechLink Staff Writer via the MSU News Service
MATR Supporters (view all)
Posted in: TechLink